These findings suggest that a pathological derangement in pancreatic tissues already triggers the release of these two proteins into the bloodstream (in particular, LAMC2 in cystadenoma and pancreatitis, and PTX3 in IPMN), and that further diagnostic imaging is warranted. The gene discussed is PTX3; the disease is pancreatic intraductal papillary-mucinous neoplasm.